ADM to acquire Deerland Probiotics & Enzymes

Published: 3-Nov-2021

Deerland is a provider of dietary supplements which use probiotic, prebiotic, and enzyme technology

ADM, a specialist in nutrition and agricultural origination and processing, has announced an expansion of its health and wellness product portfolio through an agreement to acquire US-based Deerland Probiotics & Enzymes.

“The microbiome represents one of ADM’s six strategic growth platforms, and with global demand for health and wellness products estimated at more than $775 billion, today’s investment represents a significant step forward for ADM,” said ADM Chair and CEO Juan Luciano. “Deerland Probiotics & Enzymes is a leader in probiotic, prebiotic and enzyme technology, with global sales and manufacturing in the US and Europe, and is a perfect fit for our growing portfolio of functional ingredients and solutions for health-conscious consumers. We expect the addition of the Deerland capabilities and portfolio to deliver synergies for our health & wellness business and support growth across our nutrition business unit.”

Deerland is a provider of dietary supplements which use probiotic, prebiotic, and enzyme technology, including 12 branded product lines across digestive health, immune health, women’s health, food intolerance, sports nutrition, cellular repair, and systemic and cardiovascular health. The company’s products and solutions include spore probiotics, which offer enhanced stability in food and beverage, pet nutrition and supplement applications. The company operates five manufacturing facilities, one fermentation facility, and eight R&D and quality control laboratories.

“The hand-in-glove fit of Deerland’s vast portfolio of branded technologies, clinical studies and world-class dosage form production capabilities combined with ADM’s Health and Wellness solutions is strong and unparalleled, allowing us to provide our dietary supplement, food/beverage and companion animal customers with a much broader array of products and capabilities,” said Scott Ravech, Deerland Probiotics & Enzymes CEO. “The Deerland team could not be more excited at the opportunity to be a part of the ADM family.”

The acquisition is part of a series of investments ADM has made with the aim of building a health & wellness business to help meet growing demand. Upon completion, Deerland’s approximately 320 colleagues will transfer to ADM.

You may also like